Prothena‘s potentially disease-modifying treatment for Parkinson’s disease, PRX002, met the primary objective in a Phase 1b multiple ascending dose clinical trial. The drug was found to be safe and well tolerated. PRX002 was also found to deeply penetrate the central nervous system in all doses tested. Levels of free…
Intec Pharma recently announced that the protocol for the global Phase 3 Accordance clinical trial (NCT02605434) has been amended. The Accordance trial, which is currently recruiting patients, is evaluating the Accordion Pill Carbidopa/Levodopa to treat symptoms of Parkinson’s disease in patients with advanced stage disease. Following suggestions…
The Parkinson’s Disease Foundation (PDF) is marking this year’s National Family Caregivers Month by offering a set of free resources to address the unmet needs reported by care partners of Parkinson’s disease patients. PDF is a division of the Parkinson’s Foundation, formed recently by a merger of PDF…
A new study showed that treadmill training with a virtual reality component reduced fall rates compared to treadmill training alone in a group of older adults with Parkinson’s disease, dementia, or mild cognitive impairment. The research paper, “Addition of a non-immersive virtual reality component to treadmill training to reduce fall…
Intec Pharma has been granted a Chinese patent  covering the company’s Accordion Pill, an experimental technology platform to allow for the prolonged absorption of drugs with a small absorption window, such as the combination of carbidopa and levodopa for the treatment of Parkinson’s disease (PD). The patent granted by the…
A large genome-wide study discovered a strong association between essential tremor, commonly misdiagnosed as Parkinson’s disease, and a specific gene, and less strong associations with two other genes. This is an important finding for a movement disorder that causes postural and kinetic tremor of the upper extremities,…
New research by the Leibniz-Institut für Molekulare Pharmakologie (FMP) aims to make possible the early detection of Parkinson’s disease (PD) by using strongly magnetized xenon gas to enhance magnetic resonance imaging (MRI) scans. The project, funded by a nearly $350,000 three-year award from the Michael J. Fox Foundation for Parkinson’s Research, was,…
A biomedical engineering professor from the University of Rhode Island (URI) is advancing the field of smart textiles to make Parkinson’s disease patients healthier and improve their quality of life. Kunal Mankodiya, who directs URI’s Wearable Biosensing Laboratory, is conducting research on ways to transform gloves, socks,…
The Michael J. Fox Foundation (MJFF) and Nike have so far raised $6.75 million for Parkinson’s disease research though their Nike Mag sneakers drawing and auctions this fall. The drawing and sales featured a limited-edition release of 88 pairs of the iconic Nike Mag self-lacing shoe. A final 89…
Researchers at the University of Alabama at Birmingham (UAB) were awarded a five-year $7.3 million grant from the National Institutes of Health (NIH) to evaluate new technology that could potentially improve outcomes from deep brain stimulation (DBS) in Parkinson’s disease patients. The research grant is part of the…
Get regular updates to your inbox.